Back

AI-guided population screening for cardiac ATTR amyloidosis in heart failure patients within ambulatory health service's database

28 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Diagnosis and risk stratification in cardiac amyloidosis Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ilia Davarashvili

The Hebrew University of Jerusalem, Jerusalem (Israel)

6 More presentations in this session

Presentation thumbnail
Lymphocyte-to–C-reactive-protein ratio is a strong predictor of mortality risk in cardiac transthyretin amyloidosis
Mr V. Cejka (Wurzburg, DE)
Abstract Slides Video
Presentation thumbnail
Idiopathic carpal tunnel syndrome as an early clinical indicator of transthyretin cardiac amyloidosis: diagnostic insights
Doctor E. Martins (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Transthyretin gene variants in a population-based study of 9,957 Finnish men and in 366 Finnish patients with hypertrophic cardiomyopathy
Doctor T. Pennanen (Kuopio, FI)
Abstract Slides Video
Presentation thumbnail
Safety, diagnostic yield and clinical utility of endomyocardial biopsy in patients with suspected cardiac amyloidosis: a 10-year consecutive single-centre experience
Doctor J. Mansell (London, GB)
Abstract Slides Video
Presentation thumbnail
Ventricular arrhythmias in ATTR-CM: frequency, disease severity and risk of sudden cardiac death
Doctor K. Knoll (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnosis and risk stratification in cardiac amyloidosis

The Event

Event poster

ESC Congress 2026

28 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Multimodal screening of transthyretin amyloid cardiomyopathy through artificial intelligence applied to electrocardiographic images and point-of-care ultrasound: a multi-center study
17 May 2025
thumbnail
Congress Session
Cardiac amyloidosis: my heart is filled with so much…
30 August 2024
thumbnail
Congress Presentation
Screening performance of a deep learning model versus an automated wall thickness score in biopsy-proven cardiac amyloidosis
28 August 2026
thumbnail
Congress Presentation
Diagnosis of transthyretin amyloid cardiomyopathy using automated myocardial segmentation and CT-based radiomic phenotyping
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources